glp-1 digital health news A new report from Gallup shows Americans' use of drugs for weight loss has nearly quadrupled in the last two years Dr. Angela Fitch on GLP-1

As a once-weekly subcutaneous injection, tirzepatide works by enhancing insulin secretion in response to meals, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways

Supply-demand comparison. On the substance, Grossman painted a picture of an agency that took the manufacturers spreadsheets at face value

A trial of riboflavin therapy should be offered to all FADS-deficient individuals while awaiting mutational analysis

Companies may face legal action from consumers, regulatory authorities, or other stakeholders if their products are found to be unsafe or of poor quality